Lower calcium levels in hair of Parkinson’s disease patients are associated with presence of sleeping disturbances

References

• Oerlemans WG, de Weerd AW. The prevalence of sleep disorders in patients with Parkinson’s disease. A self-reported, community-based survey. Sleep Med. 2002;3:147–9.
   PubMed Web of Science ®Google Scholar
• Friedman JH, Millman RP. Sleep disturbances and Parkinson’s disease. CNS Spectr. 2008;13:12–7.
   PubMed Web of Science ®Google Scholar
• Postuma RB, Iranzo A, Hu M, Högl B, Boeve BF, Manni R, et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain. 2019;142:744–59. doi:10.1093/brain/awz030.
   PubMed Web of Science ®Google Scholar
• Santos ABD, Campos SL, Ribeiro S, Morales L, Gonzalez J, Dos Santos Trindade J, et al. Relação entre qualidade do sono e funções cognitivas em pacientes com doença de Parkinson. Univ Sci. 2013;18:269–81. doi:10.11144/Javeriana.SC18-3.rqsf.
   Google Scholar
• dos Santos AB, Barreto GE, Kohlmeier KA. Treatment of sleeping disorders should be considered in clinical management of Parkinson’s disease. Front Aging Neurosci. 2014;6:273. doi:10.3389/fnagi.2014.00273.
   PubMed Web of Science ®Google Scholar
• Boeve BF. Idiopathic REM sleep behaviour disorder in the development of Parkinson’s disease. Lancet Neurol. 2013;12:469–82. doi:10.1016/S1474-4422(13)70054-1.
   PubMed Web of Science ®Google Scholar
• Gagnon J-F, Postuma RB, Montplaisir J. Update on the pharmacology of REM sleep behavior disorder. Neurology. 2006;67:742–7. doi:10.1212/01.wnl.0000233926.47469.73.
   PubMed Web of Science ®Google Scholar
• Vendette M, Gagnon J-F, Décary A, Massicotte-Marquez J, Postuma RB, Doyon J, et al. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology. 2007;69:1843–9. doi:10.1212/01.wnl.0000278114.14096.74.
   PubMed Web of Science ®Google Scholar
• Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord. 2009;24:1641–9. doi:10.1002/mds.22643.
   PubMed Web of Science ®Google Scholar
• Kumar S, Bhatia M, Behari M. Sleep disorders in Parkinson’s disease. Mov Disord. 2002;17:775–81. doi:10.1002/MDS.10167.
   PubMed Web of Science ®Google Scholar
• Tandberg E, Larsen J, Karlsen K. A community-based study of sleep disorders in patients with Parkinson’s disease. Mov Disord. 1998;13:895–9. doi:10.1002/MDS.870130606.
   PubMed Web of Science ®Google Scholar
• Lees A, Blackburn N, Campbell V. The nighttime problems of Parkinson’s disease. Clin Neuropharmacol. 1988;11:512–9. doi:10.1097/00002826-198812000-00004.
   PubMed Web of Science ®Google Scholar
• Zayed J, Ducic S, Campanella G, Panisset JC, Andre P, Masson H, et al. Environmental factors in the etiology of Parkinson’s disease. Can J Neurol Sci. 1990;17:286–91.
   PubMed Web of Science ®Google Scholar
• Rybicki BA, Johnson CC, Uman J, Gorell JM. Parkinson’s disease mortality and the industrial use of heavy metals in Michigan. Mov Disord. 1993;8:87–92. doi:10.1002/mds.870080116.
   PubMed Web of Science ®Google Scholar
• Uversky VN, Li J, Fink AL. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular link between Parkinson’s disease and heavy metal exposure. J Biol Chem. 2001;276:44284–96. doi:10.1074/jbc.M105343200.
   PubMed Web of Science ®Google Scholar
• Dusek P, Roos PM, Litwin T, Schneider SA, Flaten TP, Aaseth J. The neurotoxicity of iron, copper and manganese in Parkinson’s and Wilson’s diseases. J Trace Elem Med Biol. 2015;31:193–203. doi:10.1016/j.jtemb.2014.05.007.
   PubMed Web of Science ®Google Scholar
• Forte G, Alimonti A, Violante N, Di Gregorio M, Senofonte O, Petrucci F, et al. Calcium, copper, iron, magnesium, silicon and zinc content of hair in Parkinson’s disease. J Trace Elem Med Biol. 2005;19:195–201. doi:10.1016/j.jtemb.2005.08.003.
   PubMed Web of Science ®Google Scholar
• Miyake Y, Tanaka K, Fukushima W, Sasaki S, Kiyohara C, Tsuboi Y, et al. Dietary intake of metals and risk of Parkinson’s disease: a case-control study in Japan. J Neurol Sci. 2011;306:98–102. doi:10.1016/j.jns.2011.03.035.
   PubMed Web of Science ®Google Scholar
• Zhao H-W, Lin J, Wang X-B, Cheng X, Wang J-Y, Hu B-L, et al. Assessing plasma levels of selenium, copper, iron and zinc in patients of Parkinson’s disease. PLoS One. 2013;8:e83060. doi:10.1371/journal.pone.0083060.
   PubMed Web of Science ®Google Scholar
• Fukushima T, Tan X, Luo Y, Wang P, Song J, Kanda H, et al. Heavy metals in blood and urine and its relation to depressive symptoms in Parkinson’s disease patients. Fukushima J Med Sci. 2013;59:76–80. doi:10.5387/fms.2014-8.
   PubMedGoogle Scholar
• AB d, Kohlmeier KA, Rocha ME, Barreto GE, Barreto JA, de Souza ACA, et al. Hair in Parkinson’s disease patients exhibits differences in calcium, Iron and Zinc concentrations measured by flame atomic absorption spectrometry − FAAS. J Trace Elem Med Biol. 2018;47:134–9. doi:10.1016/j.jtemb.2018.02.003.
   PubMed Web of Science ®Google Scholar
• Bertolazi AN, Fagondes SC, Hoff LS, Dartora EG, da silva miozzo IC, de barba MEF, et al. Validation of the Brazilian Portuguese version of the Pittsburgh sleep quality index. Sleep Med. 2011;12:70–5. doi:10.1016/j.sleep.2010.04.020.
   PubMed Web of Science ®Google Scholar
• Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. Quantification of sleepiness: a new approach. Psychophysiology. 1973;10:431–6. doi:10.1111/j.1469-8986.1973.tb00801.x.
   PubMed Web of Science ®Google Scholar
• Boeve BF. REM sleep behavior disorder. Ann N Y Acad Sci. 2010;1184:15–54. doi:10.1111/j.1749-6632.2009.05115.x.
   PubMed Web of Science ®Google Scholar
• Rahman MA, Azad MAK, Hossain MI, Qusar MMAS, Bari W, Begum F, et al. Zinc, manganese, calcium, copper, and cadmium level in scalp hair samples of schizophrenic patients. Biol Trace Elem Res. 2009;127:102–8. doi:10.1007/s12011-008-8230-8.
   PubMed Web of Science ®Google Scholar
• Abbott RD, Ross GW, White LR, Tanner CM, Masaki KH, Nelson JS, et al. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology. 2005;65:1442–6. doi:10.1212/01.wnl.0000183056.89590.0d.
   PubMed Web of Science ®Google Scholar
• Arnulf I, Leu S, Oudiette D. Abnormal sleep and sleepiness in Parkinson's disease. Curr Opin Neurol. 2008;24:472–7. doi:10.1097/WCO.0b013e328305044d.
   Google Scholar
• Schaeffer E, Vaterrodt T, Zaunbrecher L, Liepelt-Scarfone I, Emmert K, Roeben B, et al. Effects of levodopa on quality of sleep and nocturnal movements in Parkinson’s disease. J Neurol. 2021;268:2506–14. doi:10.1007/s00415-021-10419-7.
   PubMed Web of Science ®Google Scholar
• Ondo WG, Vuong KD, Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol. 2002;59:421–4. doi:10.1001/archneur.59.3.421.
   PubMed Web of Science ®Google Scholar
• Guerreiro TM, Nishikawa DRC, Ferreira LC, Melo H, Prado R. Restless legs syndrome in Parkinson’s disease: clinical characteristics and biochemical correlations. Arq Neuropsiquiatr. 2010;68:869–72. doi:10.1590/S0004-282X2010000600007.
   PubMed Web of Science ®Google Scholar
• Piao Y-S, Lian T-H, Hu Y, Zuo L-J, Guo P, Yu S-Y, et al. Restless legs syndrome in Parkinson disease: clinical characteristics, abnormal iron metabolism and altered neurotransmitters. Sci Rep. 2017;7:10547. doi:10.1038/s41598-017-10593-7.
   PubMed Web of Science ®Google Scholar
• Leung W, Singh I, McWilliams S, Stockler S, Ipsiroglu OS. Iron deficiency and sleep - a scoping review. Sleep Med Rev. 2020;51:101274. doi:10.1016/j.smrv.2020.101274.
   PubMed Web of Science ®Google Scholar
• Barichella M, Cereda E, Iorio L, Pinelli G, Ferri V, Cassani E, et al. Clinical correlates of serum 25-hydroxyvitamin D in Parkinson’s disease. Nutr Neurosci. 2020: 1. doi:10.1080/1028415X.2020.1840117.
   Web of Science ®Google Scholar
• Gao Q, Kou T, Zhuang B, Ren Y, Dong X, Wang Q. The association between vitamin D deficiency and sleep disorders: a systematic review and meta-analysis. Nutr. 2018;10:1395. doi:10.3390/NU10101395.
   Google Scholar
• Bocca B, Alimonti A, Senofonte O, Pino A, Violante N, Petrucci F, et al. Metal changes in CSF and peripheral compartments of parkinsonian patients. J Neurol Sci. 2006;248:23–30. doi:10.1016/j.jns.2006.05.007.
   PubMed Web of Science ®Google Scholar
• Pande MBS, Nagabhushan P, Hegde ML, Rao TSS, Rao KSJ. An algorithmic approach to understand trace elemental homeostasis in serum samples of Parkinson disease. Comput Biol Med. 2005;35:475–93. doi:10.1016/j.compbiomed.2004.04.003.
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol. 2006;5:235–45. doi:10.1016/S1474-4422(06)70373-8.
   PubMed Web of Science ®Google Scholar
• Bootman MD, Berridge MJ. The elemental principles of calcium signaling. Cell. 1995;83:675–8. doi:10.1016/0092-8674(95)90179-5.
   PubMed Web of Science ®Google Scholar
• Mintz IM, Sabatini BL, Regehr WG. Calcium control of transmitter release at a cerebellar synapse. Neuron. 1995;15:675–88. doi:10.1016/0896-6273(95)90155-8.
   PubMed Web of Science ®Google Scholar
• Qian J, Colmers WF, Saggau P. Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: modulation of presynaptic Ca2+ entry. J Neurosci. 1997;17:8169–77. doi: 1997/10/23 00:01.
   PubMed Web of Science ®Google Scholar
• Mamelak M. Parkinson’s disease, the dopaminergic neuron and gammahydroxybutyrate. Neurol Ther. 2018;7:5–11. doi:10.1007/s40120-018-0091-2.
   PubMed Web of Science ®Google Scholar
• Neske GT. The slow oscillation in cortical and thalamic networks: mechanisms and functions. Front Neural Circuits. 2016;9:88. doi:10.3389/fncir.2015.00088.
   PubMed Web of Science ®Google Scholar
• Massimini M, Amzica F. Extracellular calcium fluctuations and intracellular potentials in the cortex during the slow sleep oscillation. J Neurophysiol. 2001;85:1346–50.
   PubMed Web of Science ®Google Scholar
• Nedergaard S, Flatman JA, Engberg I. Nifedipine- and omega-conotoxin-sensitive Ca2+ conductances in Guinea-pig substantia nigra pars compacta neurones. J Physiol. 1993;466:727–47. doi:10.1113/jphysiol.1993.sp019742.
   PubMed Web of Science ®Google Scholar
• Mercuri NB, Bonci A, Calabresi P, Stratta F, Stefani A, Bernardi G. Effects of dihydropyridine calcium antagonists on rat midbrain dopaminergic neurones. Br J Pharmacol. 1994;113:831–8.
   PubMed Web of Science ®Google Scholar
• Mossavar-Rahmani Y, Jung M, Patel SR, Sotres-Alvarez D, Arens R, Ramos A, et al. Eating behavior by sleep duration in the hispanic community health study/study of latinos. Appetite. 2015;95:275–84. doi:10.1016/j.appet.2015.07.014.
   PubMed Web of Science ®Google Scholar
• Grandner MA, Jackson N, Gerstner JR, Knutson KL. Sleep symptoms associated with intake of specific dietary nutrients. J Sleep Res. 2014;23:22–34. doi:10.1111/jsr.12084.
   PubMed Web of Science ®Google Scholar
• Liebman M, Chopin LF, Carter E, Clark AJ, Disney GW, Hegsted M, et al. Factors related to blood pressure in a biracial adolescent female population. Hypertension. 1986;8:843–50. doi:10.1161/01.HYP.8.10.843.
   PubMed Web of Science ®Google Scholar